-
公开(公告)号:EP2291089A1
公开(公告)日:2011-03-09
申请号:EP09733245.6
申请日:2009-04-08
申请人: Nestec S.A.
CPC分类号: C12N1/20 , A23K10/18 , A23K20/163 , A23L33/135 , A23L33/21 , A61K35/745
摘要: The present invention relates in general to edible compositions comprising probiotics. One embodiment of the present invention relates to an edible composition comprising Bifidobacterium longum, preferably Bifidobacterium longum ATCC BAA-999 and/or its fermented growth medium. This composition can be used to attenuate reductions in hippocampal BDNF expression and/or to treat or prevent anxiety and related disorders.
-
公开(公告)号:EP1940248B1
公开(公告)日:2009-12-16
申请号:EP06806927.7
申请日:2006-10-02
申请人: Nestec S.A.
CPC分类号: A23L1/3008 , A23L33/12 , A23L33/135 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A61K31/202 , A61K31/702 , A61K35/747 , A61K45/06 , A23V2250/1862 , A23V2250/1868 , A23V2250/5028 , A23V2250/5062 , A23V2200/3204 , A23V2200/3202 , A23V2250/0644 , A23V2250/70 , A23V2250/156 , A61K2300/00
-
公开(公告)号:EP1675601B1
公开(公告)日:2009-07-01
申请号:EP04790307.5
申请日:2004-10-12
申请人: Nestec S.A.
CPC分类号: A61K35/12 , A61K36/064 , A61K38/018 , Y02A50/409 , Y02A50/471 , Y02A50/473 , Y02A50/481 , Y02A50/483 , A61K2300/00
摘要: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
-
公开(公告)号:EP1638416A2
公开(公告)日:2006-03-29
申请号:EP04763015.7
申请日:2004-06-22
申请人: NESTEC S.A.
发明人: GARCIA-RODENAS, Clara, Lucia , BERGONZELLI, Gabriela , ROCHAT, Florence , TURINI, Marco, Enrico , CORTHESY-THEULAZ, Irene , CHERBUT, Christine
CPC分类号: A61K31/736 , A23L33/12 , A23L33/135 , A23L33/19 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A23Y2300/55 , A61K31/202 , A61K31/702 , A61K31/733 , A23V2250/71 , A23V2250/712 , A23V2250/708 , A23V2250/714 , A23V2250/704 , A23V2250/54246 , A23V2250/5114 , A23V2250/60 , A23V2250/18 , A23V2250/1638 , A23V2250/70 , A23V2250/0616 , A23V2250/5488 , A23V2250/1614 , A23V2250/16 , A23V2250/1592 , A23V2250/1588 , A23V2250/1642 , A23V2250/1868 , A23V2250/5062 , A23V2250/156 , A23V2250/0612 , A23V2250/641 , A23V2250/628 , A23V2250/612 , A61K2300/00
摘要: The present invention pertains to a composition for inducing a pattern of gut barrier maturation similar to that observed with breast-feeding and able to improve gut barrier maturation, e.g. during neonatal stress. In particular, the present invention relates to an infant formula containing a combination of specific ingredients designed to provide a synergistic effect all along gastrointestinal tract and barrier function.
-
公开(公告)号:EP1638416B1
公开(公告)日:2013-05-01
申请号:EP04763015.7
申请日:2004-06-22
申请人: Nestec S.A.
发明人: GARCIA-RODENAS, Clara, Lucia , BERGONZELLI, Gabriela , ROCHAT, Florence , TURINI, Marco, Enrico , CORTHESY-THEULAZ, Irene , CHERBUT, Christine
CPC分类号: A61K31/736 , A23L33/12 , A23L33/135 , A23L33/19 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A23Y2300/55 , A61K31/202 , A61K31/702 , A61K31/733 , A23V2250/71 , A23V2250/712 , A23V2250/708 , A23V2250/714 , A23V2250/704 , A23V2250/54246 , A23V2250/5114 , A23V2250/60 , A23V2250/18 , A23V2250/1638 , A23V2250/70 , A23V2250/0616 , A23V2250/5488 , A23V2250/1614 , A23V2250/16 , A23V2250/1592 , A23V2250/1588 , A23V2250/1642 , A23V2250/1868 , A23V2250/5062 , A23V2250/156 , A23V2250/0612 , A23V2250/641 , A23V2250/628 , A23V2250/612 , A61K2300/00
-
公开(公告)号:EP1675601B2
公开(公告)日:2013-04-10
申请号:EP04790307.5
申请日:2004-10-12
申请人: Nestec S.A.
CPC分类号: A61K35/12 , A61K36/064 , A61K38/018 , Y02A50/409 , Y02A50/471 , Y02A50/473 , Y02A50/481 , Y02A50/483 , A61K2300/00
摘要: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
-
公开(公告)号:EP1940248A1
公开(公告)日:2008-07-09
申请号:EP06806927.7
申请日:2006-10-02
申请人: Nestec S.A.
CPC分类号: A23L1/3008 , A23L33/12 , A23L33/135 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A61K31/202 , A61K31/702 , A61K35/747 , A61K45/06 , A23V2250/1862 , A23V2250/1868 , A23V2250/5028 , A23V2250/5062 , A23V2200/3204 , A23V2200/3202 , A23V2250/0644 , A23V2250/70 , A23V2250/156 , A61K2300/00
摘要: This invention relates to a nutritional formulation comprising an n3 long-chain polyunsaturated fatty acid (LC-PUFA), a prebiotic fibre and a probiotic bacterial strain which ingredients act together in a synergistic fashion to promote catch-up growth in young mammals whose growth has been retarded because the young mammal has been subjected to physical or mental stress.
-
公开(公告)号:EP1689417A2
公开(公告)日:2006-08-16
申请号:EP04790343.0
申请日:2004-10-13
申请人: NESTEC S.A.
CPC分类号: A61K36/06 , Y02A50/409 , Y02A50/471 , Y02A50/473 , Y02A50/481 , A61K2300/00
摘要: The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
-
公开(公告)号:EP1675601A2
公开(公告)日:2006-07-05
申请号:EP04790307.5
申请日:2004-10-12
申请人: NESTEC S.A.
CPC分类号: A61K35/12 , A61K36/064 , A61K38/018 , Y02A50/409 , Y02A50/471 , Y02A50/473 , Y02A50/481 , Y02A50/483 , A61K2300/00
摘要: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
-
-
-
-
-
-
-
-